FDA approves $2.9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition.

Related Keywords

California , United States , Pennsylvania , Henry Fuchs , Margaret Ragni , Drug Administration , Hemophilia Center , Pittsburgh Biomarin , San Rafael ,